Evidence map›Paper›PMID 39378424›Full record

ArticleJMIR research protocols2024

Investigating Exposure and Hazards of Micro- and Nanoplastics During Pregnancy and Early Life (AURORA Project): Protocol for an Interdisciplinary Study.

Amanda M Durkin, Runyu Zou, Justin M Boucher, Matthew Sp Boyles, Jeske van Boxel, Mariona Bustamante, Emily A Christopher, Payam Dadvand, Hanna M Dusza, Majorie van Duursen and 18 more

Abstract read
In one paragraph

Article in JMIR research protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Micro and Nanoplastics and Obstetric Outcomes in Humans and Animals: A Systematic Review.International journal of environmental research and public health · 2026
    Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Amanda M DurkinDepartment of Global Public Health and Bioethics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.ORCID 0009-0001-4022-6464
Runyu ZouDepartment of Global Public Health and Bioethics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.ORCID 0000-0001-7385-9498
Justin M BoucherFood Packaging Forum Foundation, Zurich, Switzerland.ORCID 0000-0003-0517-7043
Matthew Sp BoylesInstitute of Occupational Medicine (IOM), Edinburgh, United Kingdom.ORCID 0000-0003-4291-4903
Jeske van BoxelAmsterdam Institute for Life and Environment, section Environmental Health and Toxicology, Faculty of Science, Vrije Universiteit, Amsterdam, Netherlands.ORCID 0000-0003-0318-1356
Mariona BustamanteISGlobal, Barcelona, Spain.ORCID 0000-0003-0127-2860
Emily A ChristopherInstitute of Occupational Medicine (IOM), Edinburgh, United Kingdom.ORCID 0009-0008-4561-0431
Payam DadvandISGlobal, Barcelona, Spain.ORCID 0000-0002-2325-1027
Hanna M DuszaDivision of Toxicology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, Netherlands.ORCID 0000-0002-2011-3710
Majorie van DuursenAmsterdam Institute for Life and Environment, section Environmental Health and Toxicology, Faculty of Science, Vrije Universiteit, Amsterdam, Netherlands.ORCID 0000-0002-3838-9731
Markus M ForsbergSchool of Pharmacy, University of Eastern Finland, Kuopio, Finland.ORCID 0000-0002-0335-8142
Karen S GaleaInstitute of Occupational Medicine (IOM), Edinburgh, United Kingdom.ORCID 0000-0002-9540-8513
Juliette LeglerDivision of Toxicology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, Netherlands.ORCID 0000-0001-6321-1567
Laurens Db MandemakerDivision of Toxicology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, Netherlands.ORCID 0000-0003-2630-7855
Florian MeirerInorganic Chemistry and Catalysis Group, Institute for Sustainable and Circular Chemistry and Debye Institute for Nanomaterials Science, Utrecht University, Utrecht, Netherlands.ORCID 0000-0001-5581-5790
Jane MunckeFood Packaging Forum Foundation, Zurich, Switzerland.ORCID 0000-0002-6942-0594
Tim S NawrotCentre for Environmental Sciences, Hasselt University, Diepenbeek, Belgium.ORCID 0000-0002-3583-3593
Petra PřibylováRECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic.ORCID 0000-0001-8546-3546
Anna R RobuckDepartment of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States.ORCID 0000-0002-3331-7579
Nelly D SaenenCentre for Environmental Sciences, Hasselt University, Diepenbeek, Belgium.ORCID 0000-0002-3226-089X
Barbara M Scholz-BöttcherInstitute for Chemistry and Biology of the Marine Environment, Carl von Ossietzky University of Oldenburg, Oldenburg, Germany.ORCID 0000-0002-3287-4218
Kuanliang ShaoGangarosa Department of Environmental Health, Emory University Rollins School of Public Health, Atlanta, GA, United States.ORCID 0000-0002-4815-9163
Martine VrijheidISGlobal, Barcelona, Spain.ORCID 0000-0002-7090-1758
Douglas I WalkerGangarosa Department of Environmental Health, Emory University Rollins School of Public Health, Atlanta, GA, United States.ORCID 0000-0003-2912-398X
Lisa ZimmermannFood Packaging Forum Foundation, Zurich, Switzerland.ORCID 0000-0001-6801-6859
Laura M ZoutendijkInorganic Chemistry and Catalysis Group, Institute for Sustainable and Circular Chemistry and Debye Institute for Nanomaterials Science, Utrecht University, Utrecht, Netherlands.ORCID 0009-0008-7892-180X
Virissa LentersDepartment of Global Public Health and Bioethics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.ORCID 0000-0002-0444-9150
Roel VermeulenDepartment of Global Public Health and Bioethics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.ORCID 0000-0003-4082-8163

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMicro- and nanoplastics (MNPs) are emerging pollutants of concern with ubiquitous presence in global ecosystems. MNPs pose potential implications for human health; however, the health impacts of MNP exposures are not yet understood. Recent evidence suggests that MNPs can cross the placental barrier, underlying the urgent need to understand their impact on reproductive health and development.

objectiveThe Actionable eUropean ROadmap for early-life health Risk Assessment of micro- and nanoplastics (AURORA) project will investigate MNP exposures and their biological and health effects during pregnancy and early life, which are critical periods due to heightened vulnerability to environmental stressors. The AURORA project will enhance exposure assessment capabilities for measuring MNPs, MNP-associated chemicals, and plastic additives in human tissues, including placenta and blood.

methodsIn this interdisciplinary project, we will advance methods for in-depth characterization and scalable chemical analytical strategies, enabling high-resolution and large-scale toxicological, exposure assessment, and epidemiological studies. The AURORA project performs observational studies to investigate determinants and health impacts of MNPs by including 800 mother-child pairs from 2 existing birth cohorts and 110 women of reproductive age from a newly established cohort. This will be complemented by toxicological studies using a tiered-testing approach and epidemiological investigations to evaluate associations between maternal and prenatal MNP exposures and health perturbations, such as placental function, immune-inflammatory responses, oxidative stress, accelerated aging, endocrine disruption, and child growth and development. The ultimate goal of the AURORA project is to create an MNP risk assessment framework and identify the remaining knowledge gaps and priorities needed to comprehensively assess the impact of MNPs on early-life health.

resultsIn the first 3 years of this 5-year project (2021-2026), progress was made toward all objectives. This includes completion of recruitment and data collection for new and existing cohorts, development of analytical methodological protocols, and initiation of the toxicological tiered assessments. As of September 2024, data analysis is ongoing and results are expected to be published starting in 2025.

conclusionsAs plastic pollution increases globally, it is imperative to understand the impact of MNPs on human health, particularly during vulnerable developmental stages such as early life. The contributions of the AURORA project will inform future risk assessment. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/63176.

Indexed as

MicroplasticsAdultFemaleHumansMaternal ExposureNanoparticlesPregnancyRisk AssessmentMicroplasticsepidemiologymicroplasticsplacentapregnancyrisk assessmenttoxicology

Identifiers

PMID39378424
PMCPMC11496927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.